Boston Scientific Corp.’s bold attempt to snatch Guidant Corp. from Johnson & Johnson may have surprised Wall Street, but J & J; knew about overtures from its rival last month and still pressed for a better price, a regulatory filing said.
*For more on this story,
read the full Reuters article.
